Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1
Kenneth K.W. To(Chinese University of Hong Kong), Eric Huang(National Institutes of Health)
Cited by 113
Related Papers
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
|World Journal of Gastroenterology|2018|205
Targeting the <scp>ABCG</scp>2‐overexpressing multidrug resistant (<scp>MDR</scp>) cancer cells by <scp>PPAR</scp>γ agonists
|British Journal of Pharmacology|2013|35
A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors
|Scientific Reports|2016|10
Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition
|ACS Pharmacology & Translational Science|2023|8